AU2002214920A1 - Composition for aids and method producing it - Google Patents

Composition for aids and method producing it

Info

Publication number
AU2002214920A1
AU2002214920A1 AU2002214920A AU1492002A AU2002214920A1 AU 2002214920 A1 AU2002214920 A1 AU 2002214920A1 AU 2002214920 A AU2002214920 A AU 2002214920A AU 1492002 A AU1492002 A AU 1492002A AU 2002214920 A1 AU2002214920 A1 AU 2002214920A1
Authority
AU
Australia
Prior art keywords
aids
composition
method producing
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002214920A
Inventor
Yinghua Chen
Haijun Tian
Yi Xiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHINATEX INDUSTRY DEVELOPMENT CORP
Tsinghua University
Original Assignee
CHINATEX INDUSTRY DEV CORP
Tsinghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHINATEX INDUSTRY DEV CORP, Tsinghua University filed Critical CHINATEX INDUSTRY DEV CORP
Publication of AU2002214920A1 publication Critical patent/AU2002214920A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU2002214920A 2000-08-18 2001-07-20 Composition for aids and method producing it Abandoned AU2002214920A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN00123483 2000-08-18
CNB001234838A CN1172717C (en) 2000-08-18 2000-08-18 Method for treating AIDS and its preparing method
PCT/CN2001/001192 WO2002032452A1 (en) 2000-08-18 2001-07-20 Composition for aids and method producing it

Publications (1)

Publication Number Publication Date
AU2002214920A1 true AU2002214920A1 (en) 2002-04-29

Family

ID=4589903

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002214920A Abandoned AU2002214920A1 (en) 2000-08-18 2001-07-20 Composition for aids and method producing it

Country Status (3)

Country Link
CN (1) CN1172717C (en)
AU (1) AU2002214920A1 (en)
WO (1) WO2002032452A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003275116A1 (en) * 2002-09-24 2004-04-19 Frontier Biotechnologies Co., Ltd Peptide derivative fusion inhibitors of hiv infection
CN108779168A (en) 2015-12-05 2018-11-09 沃迪奥斯大学医院中心 HIV bonding agents
WO2020012435A1 (en) 2018-07-13 2020-01-16 Lausanne University Hospital Hiv binding agents
EP3996815A2 (en) 2019-07-15 2022-05-18 Lausanne University Hospital Hiv binding agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459060A (en) * 1989-08-24 1995-10-17 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
JPH08503704A (en) * 1992-11-23 1996-04-23 プレジデント アンド フェロウズ オブ ハーバード カレッジ GP41 variants and their use as HIV therapeutics
AU693098B2 (en) * 1993-06-09 1998-06-25 Connaught Laboratories Limited Tandem synthetic HIV-1 peptides
US5380668A (en) * 1993-07-06 1995-01-10 University Of Utah Research Foundation Compounds having the antigenicity of hCG
WO1995007354A1 (en) * 1993-09-11 1995-03-16 Polymun Scientific Immunobiologische Forschung Gmbh Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains

Also Published As

Publication number Publication date
CN1339318A (en) 2002-03-13
CN1172717C (en) 2004-10-27
WO2002032452A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
EP1157707B8 (en) Method and composition for deforming soft tissues
AU2002213831A1 (en) Actuating member and method for producing the same
AU2002224154A1 (en) Method for producing polybutene
AU2001227573A1 (en) Ceramics and process for producing
EP1341622B8 (en) Folded-seam connection, method of producing it and device
AU2001274513A1 (en) Image forming method
AU2001279850A1 (en) Method and arrangement for studsystem
AU2002213972A1 (en) Method for producing polyisobutenylphenoles
AU4112401A (en) Hydrophilic member and method for manufacture thereof
AU2001263822A1 (en) Method for producing ditaurine and salts thereof
AU2001233932A1 (en) Method and composition
AU2002231683A1 (en) Method of producing alk-3-ene-1-ols
AU2001245373A1 (en) Commutator and method for manufacture
AU2001264134A1 (en) Microconnectors and method for their production
AU2002211285A1 (en) Method of making nanoshells
AU2001237530A1 (en) Method
AU2001272757A1 (en) Process for producing 5-fluorooxyindole and for producing intermediate therefor
AU7965301A (en) Method for producing polyisobutenes
AU2002214920A1 (en) Composition for aids and method producing it
AUPR909101A0 (en) Soil based material and method for producing same
AU2002239775A1 (en) Chemical-library composition and method
AU2001241636A1 (en) Halotherapy method
AU2002212224A1 (en) Method for producing delta1-pyrrolines
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2001264000A1 (en) Phosphomagnesium mortar and method for obtaining same